Sign in
Active, not recruitingNo phase

Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Key facts

Who runs it
Apifix
Where
Atlanta, Charlottesville, Cleveland, Columbia, Dayton, Indianapolis, Jackson, Jacksonville, Kansas City, New York, Rochester, San Diego, Sioux Falls, and St Louis, United StatesSee the 14 sites
Trial code
Status
Active, not recruiting
People taking part
201 people enrolled
Started
31 May 2020
Expected to end
30 Jun 2030
Type of study
Interventional
Treatments tested
  • MID-C System
Record updated
3 October 2025

Who can take part

Age
10 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Adolescent Idiopathic Scoliosis classified as Lenke Type 1 or Type 5 curves
  • Cobb angle between 35-60 degrees (inclusive)
  • Flexible curve that that reduces to ≤ 30 degrees on lateral side-bending radiographs or as evident by traction x-ray
  • Kyphosis angles of ≤ 55 degrees measured from T5 to T12
  • Appropriate candidate for posterior surgical approach
  • Patient has good general health
  • Patient has no known hypersensitivity or allergies to titanium
  • Patient's guardian signs a written informed consent form (ICF)

Who cannot take part

  • Previous spine surgery that would prevent the successful performance of the MID-C system
  • Known history of existing malignancy, or any systemic or local infection
  • Active systemic disease, such as AIDS, HIV, or active infection
  • Active infection or the skin is compromised at the surgical site
  • Systemic disease that would affect the Patient's welfare or overall outcome of the study
  • Any type of non-idiopathic scoliosis
  • Any main thoracic deformity that includes vertebral levels and cranial including to T2
  • Spinal cord abnormalities that require treatment
  • Known neurological deficit (defined as motor grade < 5/5)
  • Known poor bone quality defined as T score -1.5 or less
  • For female Patient, pregnancy

Where in United States

  • WellstarAtlanta, United States
  • University of VirginiaCharlottesville, United States
  • Rainbow babies and childrenCleveland, United States
  • Women and Children's Hospital - University of Missouri Health CareColumbia, United States
  • Dayton Children's HospitalDayton, United States
  • Riley Children's HealthIndianapolis, United States
  • Univ. of Mississippi Medical Center (UMMC)Jackson, United States
  • Wolfson Children's HospitalJacksonville, United States
  • Children's Mercy HospitalKansas City, United States
  • Mount Sinai HospitalNew York, United States
  • Mayo ClinicRochester, United States
  • Rady Children's HospitalSan Diego, United States
  • Avera HealthSioux Falls, United States
  • Shriners Hospitals for ChildrenSt Louis, United States

About the trial

What the trial wants to find out

The ApiFix MID-C System is a unidirectional expandable rod, designed to be connected unilaterally to the spine via 2 anchor points on the concave side of a scoliotic deformity above and below the apex of the major curvature to treat adolescent idiopathic scoliosis. The MID-C System is designed to act as an internal brace. Patients implanted with the device in the US within 2 years of FDA's approval of H17001 should be enrolled in the study. A minimum number of 200 patients will be enrolled in this study.

The group in the trial

  • MID-C treatmentTreatment being tested

    Treatment: MID-C System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
3 October 2025